BittooKanwarMD
Pediatric Gastroenterology • San Francisco, CAAssistant Professor, Pediatrics, UCSF School of Medicine
Are you Dr. Kanwar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
500 Parnassus Ave
Mu4e
San Francisco, CA 94143Phone+1 415-476-5892Fax+1 415-476-1343
Summary
- Dr. Bittoo Kanwar, MD is a pediatric gastroenterologist in San Francisco, California. He is currently licensed to practice medicine in California. He is affiliated with UCSF Medical Center and is an Assistant Professor at UCSF School of Medicine.
Education & Training
University of California (San Francisco)Fellowship, Pediatric Gastroenterology, 2005 - 2009
Rush University Medical CenterResidency, Pediatrics, 2002 - 2005
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2005 - 2023
Clinical Trials
- A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C Start of enrollment: 2010 Oct 01
- A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C Start of enrollment: 2010 Oct 01
- GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus Start of enrollment: 2011 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 25 citationsPTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis.William J. Sandborn, Larry C. Mattheakis, Nishit B. Modi, David Pugatch, Brian Bressler
Gastroenterology. 2021-12-01 - 71 citationsSofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection.Stefan Wirth, Philip J. Rosenthal, Regino P. Gonzalez-Peralta, Maureen M. Jonas, William F. Balistreri
Hepatology. 2017-10-01 - 125 citationsThe safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection.William F. Balistreri, Karen F. Murray, Philip J. Rosenthal, Sanjay Bansal, Chuan Hao Lin
Hepatology. 2017-08-01
